Exosomal delivery of therapeutic modulators through the blood–brain barrier; promise and pitfalls

M Heidarzadeh, Y Gürsoy-Özdemir, M Kaya… - Cell & Bioscience, 2021 - Springer
Nowadays, a large population around the world, especially the elderly, suffers from
neurological inflammatory and degenerative disorders/diseases. Current drug delivery …

Engineering nanosystems to overcome barriers to cancer diagnosis and treatment

SO Alhaj-Suliman, EI Wafa, AK Salem - Advanced drug delivery reviews, 2022 - Elsevier
Over the past two decades, multidisciplinary investigations into the development of
nanoparticles for medical applications have continually increased. However, nanoparticles …

ApoE-targeting increases the transfer of solid lipid nanoparticles with donepezil cargo across a culture model of the blood–brain barrier

GR Topal, M Mészáros, G Porkoláb, A Szecskó… - Pharmaceutics, 2020 - mdpi.com
Pharmacological treatment of central nervous system (CNS) disorders is difficult, because
the blood–brain barrier (BBB) restricts the penetration of many drugs into the brain. To solve …

Glycocalyx regulates the strength and kinetics of cancer cell adhesion revealed by biophysical models based on high resolution label-free optical data

N Kanyo, KD Kovacs, A Saftics, I Szekacs, B Peter… - Scientific reports, 2020 - nature.com
The glycocalyx is thought to perform a potent, but not yet defined function in cellular
adhesion and signaling. Since 95% of cancer cells have altered glycocalyx structure, this …

Penetration of the SARS-CoV-2 spike protein across the blood–brain barrier, as revealed by a combination of a human cell culture model system and optical …

D Petrovszki, FR Walter, JP Vigh, A Kocsis, S Valkai… - Biomedicines, 2022 - mdpi.com
Since the outbreak of the global pandemic caused by severe acute respiratory coronavirus 2
(SARS-CoV-2), several clinical aspects of the disease have come into attention. Besides its …

Surface charge, glycocalyx, and blood-brain barrier function

FR Walter, AR Santa-Maria, M Mészáros… - Tissue …, 2021 - Taylor & Francis
The negative surface charge of brain microvessel endothelial cells is derived from the
special composition of their membrane lipids and the thick endothelial surface glycocalyx …

Boosting the brain delivery of Atazanavir through nanostructured lipid carrier-based approach for mitigating neuroaids

SA Khan, S Rehman, B Nabi, A Iqubal, N Nehal… - Pharmaceutics, 2020 - mdpi.com
Atazanavir (ATZ) presents poor brain availability when administered orally, which poses a
major hurdle in its use as an effective therapy for the management of NeuroAIDS. The …

Mechanistic understanding from molecular dynamics in pharmaceutical research 2: lipid membrane in drug design

T Róg, M Girych, A Bunker - Pharmaceuticals, 2021 - mdpi.com
We review the use of molecular dynamics (MD) simulation as a drug design tool in the
context of the role that the lipid membrane can play in drug action, ie, the interaction …

Nanomedicine based strategies for oligonucleotide traversion across the blood–brain barrier

E Amulya, A Sikder, G Vambhurkar, S Shah… - Journal of Controlled …, 2023 - Elsevier
Neurological disorders are considered the most prominent cause of disability worldwide.
The major hurdle in the management of neurological disorders is the existence of the blood …

Flow induces barrier and glycocalyx-related genes and negative surface charge in a lab-on-a-chip human blood-brain barrier model

AR Santa-Maria, FR Walter… - Journal of Cerebral …, 2021 - journals.sagepub.com
Microfluidic lab-on-a-chip (LOC) devices allow the study of blood-brain barrier (BBB)
properties in dynamic conditions. We studied a BBB model, consisting of human endothelial …